Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-11-18
|
5-day change | 1st Jan Change | ||
| 207,500.00 KRW | -2.58% |
|
+0.24% | +20.37% |
| Nov. 09 | Celltrion's Stekima Wins EU Backing for Expanded Use in Children | MT |
| Nov. 02 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
| Market Cap | 47,400B 35.56B 32.43B 29.99B 27.06B 50.97B 3,323B 52.97B 362B 143B 1,794B 133B 131B 5,664B | P/E 2026 * |
35.1x | P/E 2027 * | 26.1x |
|---|---|---|---|---|---|
| Enterprise Value | 49.97B 37.49M 34.19M 31.61M 28.53M 53.72M 3.5B 55.84M 382M 151M 1.89B 141M 138M 5.97B | EV / Sales 2026 * |
8.68x | EV / Sales 2027 * | 7.46x |
| Free-Float |
58.01% | Yield 2026 * |
0.37% | Yield 2027 * | 0.39% |
| 1 day | -2.58% | ||
| 1 week | +0.24% | ||
| Current month | +8.30% | ||
| 1 month | +6.96% | ||
| 3 months | +6.14% | ||
| 6 months | +18.93% | ||
| Current year | +20.37% |
| 1 week | 206,500 | 219,000 | |
| 1 month | 187,500 | 219,000 | |
| Current year | 158,500 | 239,047.62 | |
| 1 year | 158,500 | 239,047.62 | |
| 3 years | 137,362.64 | 239,047.62 | |
| 5 years | 114,250.83 | 239,047.62 | |
| 10 years | 64,487.59 | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 51 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 69 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.58% | +0.24% | +18.54% | +41.28% | 36.44B | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 66.37B | ||
| +0.59% | -1.83% | +8.98% | +90.01% | 58.86B | ||
| +0.54% | +0.45% | +25.96% | +87.77% | 55.22B | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 47.21B | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 42.45B | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 35.19B | ||
| -0.17% | -1.83% | +82.46% | +57.69% | 32.66B | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 26.73B | ||
| -0.81% | -9.41% | +38.72% | -7.75% | 24.22B | ||
| Average | -0.95% | -3.99% | +34.62% | +151.17% | 43B | |
| Weighted average by Cap. | -0.84% | -3.69% | +34.47% | +135.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,755B 4.32B 3.94B 3.64B 3.29B 6.19B 403B 6.43B 43.97B 17.38B 218B 16.2B 15.86B 688B | 6,605B 4.95B 4.52B 4.18B 3.77B 7.1B 463B 7.38B 50.46B 19.95B 250B 18.59B 18.2B 789B |
| Net income | 1,379B 1.03B 944M 873M 788M 1.48B 96.7B 1.54B 10.54B 4.17B 52.2B 3.88B 3.8B 165B | 1,835B 1.38B 1.26B 1.16B 1.05B 1.97B 129B 2.05B 14.02B 5.54B 69.43B 5.16B 5.06B 219B |
| Net Debt | 2,566B 1.92B 1.76B 1.62B 1.46B 2.76B 180B 2.87B 19.6B 7.75B 97.08B 7.22B 7.07B 307B | 1,849B 1.39B 1.27B 1.17B 1.06B 1.99B 130B 2.07B 14.13B 5.58B 69.97B 5.2B 5.1B 221B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | ₩207,500.00 | -2.58% | 437,448 |
| 26-11-17 | ₩213,000.00 | -0.70% | 350,466 |
| 26-11-16 | ₩214,500.00 | +0.23% | 352,775 |
| 26-11-13 | ₩214,000.00 | +2.15% | 436,767 |
| 26-11-12 | ₩209,500.00 | +1.21% | 569,041 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
















